Gadsden Regional Medical Center is the first in the state to use the Diamondback 360 Coronary Orbital Atherectomy System from Cardiovascular Systems, Inc.
This technology is the first evidence-based, safe treatment approved by FDA for severely calcified coronary lesions. The Diamondback 360 Coronary OAS uses a patented combination of differential sanding and centrifugal force to reduce arterial calcium that can cause complications when treating Coronary Artery Disease, a life-threatening condition. Arterial calcium is a common occurrence and can lead to significant complications, with moderate to severe arterial calcium present in nearly 40 percent of patients undergoing a percutaneous coronary intervention in the U.S.
“Gadsden Regional is at the leading edge of innovative cardiac care, and selected the revolutionary technology based on studies of its safety and effectiveness in treating severely calcified coronary lesions,” Taylor Powers, cardiovascular services director at GRMC, said. “The Diamondback 360 Coronary OAS provides our patients undergoing percutaneous coronary intervention procedures with the first evidence-based option approved by the FDA for this difficult to treat patient population.”
Dr. Bryan McGwier and Dr. Darryl Prime began using the Diamondback 360 Coronary OAS technology on March 30.
The Diamondback 360 Coronary OAS is an eccentrically mounted 1.25-millimeter diamond-coated crown that sands away calcium in severely calcified coronary arteries, enabling stent deployment. As the crown rotates and orbit increases, centrifugal force presses the crown against the lesion, reducing arterial calcium, while healthy tissue flexes away.
